Mary B. Goldring, Ph.D., senior scientist at Hospital for Special Surgery (HSS) in New York City, has been named president of the Orthopaedic Research Society (ORS). The inauguration took place at the organization’s annual meeting on March 17th, in New Orleans, with more than 2, 600 attendees.
Mary B. Goldring, Ph.D. Named President of ORS
2 min read Premium comments
Dr. Goldring is co-director of the Tissue Engineering Regeneration and Repair Program in the Research Division at HSS. She is credited with developing models for the study of human cartilage cell biology. Her research has identified molecular and cellular mechanisms underlying cartilage loss and changes involved in osteoarthritis and inflammatory joint disorders.
The mission of the Orthopaedic Research Society is to advance the global orthopedic research agenda through excellence in research, education, collaboration, communication and advocacy. The ORS has more than 2, 800 members, including orthopedic surgeons, research scientists, engineers and biologists.
“It is an honor to be named president of an organization that strives to be the world’s leading forum for the dissemination of new musculoskeletal research findings, ” Dr. Goldring said in the March 17th news release.
Dr. Goldring is currently associate editor of the Journal of Cellular Physiology, Arthritis Research and Therapy, and the Journal of Orthopedic Research. She previously served as co-editor of the journal Arthritis and Rheumatism. In addition, she has served as a member of the Board of Directors of the Osteoarthritis Research Society International and as chair of the Arthritis Foundation Molecular Biology and Genetics Study Section. She has also served on study sections for the National Institutes of Health, the Orthopaedic Research and Educational Foundation, and NASA.
Asked about her plans, Dr. Goldring told OTW, “I would like to enhance communication across the investigators in the three major disciplines of the society: clinician scientists, engineers, and basic scientists/biologists. I would also like to enhance programming for specialty meetings and the ORS Annual Meeting and new editorial composition for the Journal of Orthopaedic Research that focuses on thematic areas, which encompass the three disciplines.
“I would also like to focus on nurturing young/new investigators. For example, I will seek to partner with OREF, NIH and the Arthritis Foundation to provide grants for Ph.D. and resident fellowships and other grants for ORS members.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.